cardiovascular-agents has been researched along with Skin-Diseases* in 8 studies
1 review(s) available for cardiovascular-agents and Skin-Diseases
Article | Year |
---|---|
Drug approval highlights for 2003.
In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of particular interest to primary health care providers. The drugs include: Oxytrol (for urinary incontinence), Valtrex (for reducing the risk of heterosexual transmission of genital herpes), Femring (for vaginal delivery of hormone therapy), Uroxatral (for benign prostatic hypertrophy), Levitra (for erectile dysfunction), Flumist (for preventing influenza), Xolair (for asthma), Raptiva (for psoriasis), Cubicin (for skin infections), Crestor (for hypercholesterolemia), and Coreg (for severe heart failure). Topics: Acyclovir; Cardiovascular Agents; Cardiovascular Diseases; Dermatologic Agents; Drug Approval; Estrogen Replacement Therapy; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Immunologic Factors; Male; Mandelic Acids; Skin Diseases; Valacyclovir; Valine; Women's Health | 2004 |
7 other study(ies) available for cardiovascular-agents and Skin-Diseases
Article | Year |
---|---|
Drug-induced photosensitivity.
(1) Photosensitivity reactions are cutaneous disorders due to exposure to ultraviolet (UV) radiation of natural or artificial origin. They occur or are more prevalent on unprotected skin. The main clinical manifestations are burns, eczema-like rash, urticaria, pigmentation, or onycholysis; (2) Many drugs increase cutaneous sensitivity to UV, sometimes for therapeutic purposes, but it is generally an unwanted effect. Topics: Aminolevulinic Acid; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Agents; Dermatitis, Photoallergic; Dermatitis, Phototoxic; Dihematoporphyrin Ether; Diuretics; Doxycycline; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Eczema; Furocoumarins; Hematoporphyrin Photoradiation; Humans; Methotrexate; Onycholysis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Porphyrins; Psychotropic Drugs; Quinolines; Skin; Skin Aging; Skin Diseases; Skin Neoplasms; Skin Pigmentation; Sulfonamides; Sunscreening Agents; Tetracycline; Ultraviolet Rays; Urticaria; Verteporfin | 2009 |
[Dermatological indications of corticosteroids and derivatives].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Cardiovascular Agents; Humans; Skin Diseases | 1959 |
[Treatment of severe scalds with autonomic shielding].
Topics: Aminobenzoates; Autonomic Nervous System; Burns; Cardiovascular Agents; Child; Ergot Alkaloids; Humans; Infant; Promethazine; Skin Diseases | 1958 |
[Nystatin in the local treatment of cutaneous moniliasis; advantage of its combination with modern corticosteroids].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibiotics, Antitubercular; Candidiasis; Candidiasis, Cutaneous; Cardiovascular Agents; Dermatologic Agents; Nystatin; Skin Diseases | 1957 |
[Cortical steroids in dermatology. I. New derivatives in corticosteroids and their use in therapeutic dermatology].
Topics: Adrenal Cortex Hormones; Cardiovascular Agents; Dermatology; Glucocorticoids; Skin Diseases | 1956 |
[Treatment of roentgen irritation of organic nerves with dihydroergotamine].
Topics: Cardiovascular Agents; Dihydroergotamine; Ergot Alkaloids; Oxytocics; Skin Diseases; X-Rays | 1953 |
[Therapy of ozenous atrophic rhinitis].
Topics: Atrophy; Cardiovascular Agents; Connective Tissue Diseases; Ergot Alkaloids; Rhinitis; Rhinitis, Atrophic; Skin Diseases | 1953 |